16.09
-0.16 (-0.98%)
Penutupan Terdahulu | 16.25 |
Buka | 16.42 |
Jumlah Dagangan | 1,023,631 |
Purata Dagangan (3B) | 1,247,811 |
Modal Pasaran | 1,226,848,128 |
Harga / Pendapatan (P/E TTM) | 9.30 |
Harga / Pendapatan (P/E Ke hadapan) | 8.21 |
Harga / Jualan (P/S) | 3.38 |
Harga / Buku (P/B) | 1.77 |
Julat 52 Minggu | |
Tarikh Pendapatan | 31 Oct 2024 - 4 Nov 2024 |
Margin Keuntungan | 36.26% |
Margin Operasi (TTM) | 37.06% |
EPS Cair (TTM) | 1.83 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 5.80% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | 9.60% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 0.72% |
Nisbah Semasa (MRQ) | 10.68 |
Aliran Tunai Operasi (OCF TTM) | 161.49 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 96.60 M |
Pulangan Atas Aset (ROA TTM) | 10.50% |
Pulangan Atas Ekuiti (ROE TTM) | 21.04% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Bercampur | Bercampur |
Medical Devices (Global) | Bercampur | Bercampur | |
Stok | InMode Ltd. | Menaik | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 3.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 1.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -2.5 |
Purata | 0.50 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States. |
|
Sektor | Healthcare |
Industri | Medical Devices |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 10.76% |
% Dimiliki oleh Institusi | 64.14% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 27.00 (Barclays, 67.81%) | Beli |
Median | 26.00 (61.59%) | |
Rendah | 25.00 (BTIG, 55.38%) | Beli |
Purata | 26.00 (61.59%) | |
Jumlah | 2 Beli | |
Harga Purata @ Panggilan | 16.93 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
BTIG | 17 Oct 2024 | 25.00 (55.38%) | Beli | 17.21 |
Barclays | 14 Oct 2024 | 27.00 (67.81%) | Beli | 16.65 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2024 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |